Epitomee

Epitomee develops an ingestible device platform that deploys targeted therapies along the gastrointestinal tract. The technology utilizes a swallowable capsule designed for mechanosensory stimulation to manage weight and deliver biologics for chronic diseases. The device is engineered for controlled activation in specific regions of the stomach and small intestine before dissolving and exiting the body naturally.